Annual EBIT
-$144.89 M
-$274.47 M-211.81%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual earnings before interest & taxes is -$144.89 million, with the most recent change of -$274.47 million (-211.81%) on December 31, 2023.
- During the last 3 years, ITOS annual EBIT has fallen by -$105.58 million (-268.60%).
- ITOS annual EBIT is now -156.80% below its all-time high of $255.08 million, reached on December 31, 2021.
Performance
ITOS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$47.99 M
-$35.24 M-276.40%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly earnings before interest & taxes is -$47.99 million, with the most recent change of -$35.24 million (-276.40%) on September 30, 2024.
- Over the past year, ITOS quarterly EBIT has dropped by -$10.75 million (-28.87%).
- ITOS quarterly EBIT is now -122.38% below its all-time high of $214.48 million, reached on December 31, 2021.
Performance
ITOS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$143.47 M
-$5.76 M-4.18%
September 30, 2024
Summary
- As of February 6, 2025, ITOS TTM earnings before interest & taxes is -$143.47 million, with the most recent change of -$5.76 million (-4.18%) on September 30, 2024.
- Over the past year, ITOS TTM EBIT has increased by +$1.29 million (+0.89%).
- ITOS TTM EBIT is now -134.10% below its all-time high of $420.70 million, reached on June 30, 2022.
Performance
ITOS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ITOS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -211.8% | -28.9% | +0.9% |
| 3 y3 years | -268.6% | -159.3% | -652.1% |
| 5 y5 years | -705.8% | -620.6% | -516.6% |
ITOS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -156.8% | at low | -122.4% | at low | -134.1% | +13.8% |
| 5 y | 5-year | -156.8% | at low | -122.4% | at low | -134.1% | +13.8% |
| alltime | all time | -156.8% | at low | -122.4% | at low | -134.1% | +13.8% |
ITeos Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$47.99 M(+276.4%) | -$143.47 M(+4.2%) |
| Jun 2024 | - | -$12.75 M(-72.0%) | -$137.71 M(-17.2%) |
| Mar 2024 | - | -$45.48 M(+22.1%) | -$166.39 M(+14.9%) |
| Dec 2023 | -$144.89 M(-211.8%) | -$37.24 M(-11.8%) | -$144.76 M(+63.1%) |
| Sep 2023 | - | -$42.23 M(+1.9%) | -$88.76 M(+45.4%) |
| Jun 2023 | - | -$41.44 M(+73.7%) | -$61.03 M(+285.8%) |
| Mar 2023 | - | -$23.85 M(-227.1%) | -$15.82 M(-112.2%) |
| Dec 2022 | $129.59 M(-49.2%) | $18.76 M(-229.3%) | $129.59 M(-60.2%) |
| Sep 2022 | - | -$14.51 M(-484.4%) | $325.30 M(-22.7%) |
| Jun 2022 | - | $3.77 M(-96.9%) | $420.70 M(+7.8%) |
| Mar 2022 | - | $121.56 M(-43.3%) | $390.41 M(+53.1%) |
| Dec 2021 | $255.08 M | $214.48 M(+165.1%) | $255.08 M(+881.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $80.90 M(-405.1%) | $25.98 M(-139.4%) |
| Jun 2021 | - | -$26.52 M(+92.5%) | -$65.87 M(+41.3%) |
| Mar 2021 | - | -$13.77 M(-5.8%) | -$46.61 M(+18.6%) |
| Dec 2020 | -$39.31 M(+68.9%) | -$14.62 M(+33.5%) | -$39.31 M(+26.9%) |
| Sep 2020 | - | -$10.95 M(+50.8%) | -$30.98 M(+16.1%) |
| Jun 2020 | - | -$7.26 M(+12.3%) | -$26.68 M(+8.6%) |
| Mar 2020 | - | -$6.47 M(+2.9%) | -$24.58 M(+5.6%) |
| Dec 2019 | -$23.27 M(+29.4%) | -$6.29 M(-5.6%) | -$23.27 M(+37.0%) |
| Sep 2019 | - | -$6.66 M(+29.0%) | -$16.98 M(+64.5%) |
| Jun 2019 | - | -$5.16 M(+0.1%) | -$10.32 M(+100.1%) |
| Mar 2019 | - | -$5.16 M | -$5.16 M |
| Dec 2018 | -$17.98 M | - | - |
FAQ
- What is iTeos Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for iTeos Therapeutics?
- What is iTeos Therapeutics annual EBIT year-on-year change?
- What is iTeos Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly EBIT year-on-year change?
- What is iTeos Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for iTeos Therapeutics?
- What is iTeos Therapeutics TTM EBIT year-on-year change?
What is iTeos Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ITOS is -$144.89 M
What is the all time high annual EBIT for iTeos Therapeutics?
iTeos Therapeutics all-time high annual earnings before interest & taxes is $255.08 M
What is iTeos Therapeutics annual EBIT year-on-year change?
Over the past year, ITOS annual earnings before interest & taxes has changed by -$274.47 M (-211.81%)
What is iTeos Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ITOS is -$47.99 M
What is the all time high quarterly EBIT for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly earnings before interest & taxes is $214.48 M
What is iTeos Therapeutics quarterly EBIT year-on-year change?
Over the past year, ITOS quarterly earnings before interest & taxes has changed by -$10.75 M (-28.87%)
What is iTeos Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ITOS is -$143.47 M
What is the all time high TTM EBIT for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM earnings before interest & taxes is $420.70 M
What is iTeos Therapeutics TTM EBIT year-on-year change?
Over the past year, ITOS TTM earnings before interest & taxes has changed by +$1.29 M (+0.89%)